Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00955656
Other study ID # 110132
Secondary ID
Status Completed
Phase N/A
First received August 6, 2009
Last updated September 11, 2017
Start date July 2009
Est. completion date December 2009

Study information

Verified date September 2017
Source Arkansas Children's Hospital Research Institute
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The proposed study will utilize a survey format to examine the attitudes, perceptions, and practices of primary care providers in the Delta region of Arkansas.


Description:

Study Design. Primary care providers will be sent a providers packet to include a cover letter explaining the survey and its purpose as well as a 2-part questionnaire that includes nine selected short patient vignettes and a questionnaire regarding their personal and practice characteristics.

Study Population. Individuals who receive the survey will be the primary care provider identified by study participants enrolled in our ongoing study entitled, "Asthma in the Delta Region of Arkansas: Characterization of Disease and Impact of Environmental Factors" (ARIA#53054). We will send the survey to all identified practitioners in Lee, Phillips, Desha, Chicot, St. Francis, and surrounding counties. Future studies will include primary care providers from other Arkansas Delta counties pending funding.

Inclusion/Exclusion Criteria. We will send the survey to all identified practitioners in Lee, Phillips, Desha, Chicot, St. Francis, and surrounding counties. Future studies will include primary care providers from other Arkansas Delta counties pending funding.

Instruments. Delta Primary Care Provider Survey. The self administered survey examines the attitudes, perceptions and practices of primary care providers. The 2-part questionnaire includes nine selected short patient vignettes and a questionnaire regarding the providers personal and practice characteristics.


Recruitment information / eligibility

Status Completed
Enrollment 6
Est. completion date December 2009
Est. primary completion date December 2009
Accepts healthy volunteers No
Gender All
Age group 21 Years and older
Eligibility Inclusion Criteria:

- We will send the survey to all identified practitioners in Lee, Phillips, Desha, Chicot, St. Francis, and surrounding counties.

- Future studies will include primary care providers from other Arkansas Delta counties pending funding.

Exclusion Criteria:

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United States Arkansas Children's Hospital Research Institute Little Rock Arkansas

Sponsors (1)

Lead Sponsor Collaborator
Arkansas Children's Hospital Research Institute

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary The proposed study will utilize a survey format to examine the attitudes, perceptions, and practices of primary care providers in the Delta region of Arkansas. 6 months
See also
  Status Clinical Trial Phase
Completed NCT04624425 - Additional Effects of Segmental Breathing In Asthma N/A
Terminated NCT04410523 - Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma Phase 2
Active, not recruiting NCT03927820 - A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR) N/A
Completed NCT04617015 - Defining and Treating Depression-related Asthma Early Phase 1
Recruiting NCT03694158 - Investigating Dupilumab's Effect in Asthma by Genotype Phase 4
Terminated NCT04946318 - Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma Phase 2
Completed NCT04450108 - Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients N/A
Completed NCT03086460 - A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH) Phase 2
Completed NCT01160224 - Oral GW766944 (Oral CCR3 Antagonist) Phase 2
Completed NCT03186209 - Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE) Phase 3
Completed NCT02502734 - Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma Phase 3
Completed NCT01715844 - L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics Phase 1
Terminated NCT04993443 - First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036 Phase 1
Completed NCT02787863 - Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology Phase 4
Recruiting NCT06033833 - Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study Phase 2
Completed NCT03257995 - Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma. Phase 2
Completed NCT02212483 - Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients N/A
Recruiting NCT04872309 - MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
Withdrawn NCT01468805 - Childhood Asthma Reduction Study N/A
Recruiting NCT05145894 - Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device